Tuesday - October 27, 2026

What’s Driving the Geographic Atrophy Market Boom? Experts Forecast Strong Expansion and Competitive Shifts Through 2034 | Apellis Pharma, Iveric bio., Belite Bio, NGM Biopharma, Novartis, CellCure

The Key Geographic Atrophy Companies in the market include – Complement Therapeutics, Apellis Pharmaceuticals, Nanoscope Therapeutics, ONL Therapeutics, NGM Biopharmaceuticals, Annexon, Genentech, Belite Bio, Inc, Aviceda Therapeutics, Iveric Bio, Alkeus Pharmaceuticals, Allegro Ophthalmics, Stealth BioTherapeutics, Novartis, Perceive Biotherapeutics, Inc., Genentech, … Continue reading →

Creative Biolabs Connects Antibody Engineering with C1q and FcRn Binding Analysis

Creative Biolabs A complementary portfolio of antibody engineering, C1q binding, and FcRn binding services helps researchers investigate how molecular modifications influence candidate profiles. Shirley, New York – October 27, 2026 – Creative Biolabs supports therapeutic antibody research through engineering and Fc … Continue reading →

Age-Related Macular Degeneration Pipeline 2026: Therapeutic Candidates, Clinical Trial Insights, and Companies Leading Drug Development | Astellas Pharma, Iveric Bio, Apellis Pharma, Novartis, Alkeus

(Albany, New York) – October 27, 2026: As per DelveInsight’s assessment, globally, Age-Related Macular Degeneration pipeline constitutes 90+ key companies continuously working towards developing 100+ Age-Related Macular Degeneration treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of … Continue reading →